Compare Plug Power Inc (PLUG) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Plug Power Inc vs GeneDx Holdings Corp — how do they compare? Plug Power Inc trades at $1.76 (market cap $2.49B), while GeneDx Holdings Corp trades at $67.67 (market cap $2.04B). The key difference: Plug Power Inc is the larger of the two by market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Plug Power Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Plug Power Inc for 41 Days and GeneDx Holdings Corp for 19 Days on average.
| PLUG | WGS | |
|---|---|---|
Market Cap | $2.49B | $2.04B |
Volume | 47,846,349 | 659,215 |
Sector | Industrials | Health |
52-Week High | $4.14 | $167.51 |
52-Week Low | $1.73 | $34.51 |
Typical Hold Time | 41 Days | 19 Days |
Enterprise Value | $3.36B | $2.08B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Plug Power (PLUG) trades at $1.73, down 6.99% today, with a bearish technical signal and negative earnings momentum. The company continues to report significant losses with a -220.59% net income margin and negative cash flow, though recent electrolyzer supply agreements and international expansion provide some operational catalysts. Analyst sentiment is mixed with 44.73% buy ratings but a consensus price target of $3.13 suggesting 81% upside potential from current levels.
The stock faces substantial fundamental challenges with persistent losses and negative cash flow, but maintains analyst support due to its positioning in the growing green hydrogen market. Key risks include execution challenges in achieving profitability, high cash burn requiring continued financing, and competitive pressures in the clean energy sector. The current price near the analyst low target of $1.65 indicates limited downside protection.
GeneDx (WGS) trades at $68.53, down 4.18% today amid bearish technical signals despite recent positive earnings surprises. The stock shows mixed fundamentals with strong revenue growth to $454M in 2026 but negative profitability metrics including -23.4% net margin. Recent developments include new genomic testing products and hospital partnerships, while analyst consensus remains strongly bullish with a $81 price target representing 18% upside potential.
The investment case balances strong analyst support and genomic testing market growth against persistent profitability challenges and negative cash flow trends. Key catalysts include Q3 2026 earnings due soon and continued execution on operational improvements, while risks center on margin recovery timeline and competitive pressures in the rapidly evolving genomics space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Plug Power Inc
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.
Read more on PLUG →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
